原始 发表于 2025-3-25 04:56:39

Wilhelm Magnus,Fritz Oberhettinger at that time described benefit in chronic asthma , demonstrating the unequivocal benefit of corticosteroids in asthma. Subsequently, both oral and inhaled corticosteroids have evolved into the most important and useful drugs currently available to treat asthma

overwrought 发表于 2025-3-25 11:09:21

http://reply.papertrans.cn/17/1636/163548/163548_22.png

moribund 发表于 2025-3-25 13:14:33

http://reply.papertrans.cn/17/1636/163548/163548_23.png

mitral-valve 发表于 2025-3-25 19:34:41

Wilhelm Magnus,Fritz OberhettingerWith the increasing awareness of the importance of inflammation in the pathogenesis of asthma even in relatively mild patients , more and more emphasis is being put on anti-inflammatory approaches to treatment.

ALE 发表于 2025-3-25 22:36:46

http://reply.papertrans.cn/17/1636/163548/163548_25.png

judicial 发表于 2025-3-26 03:38:38

http://reply.papertrans.cn/17/1636/163548/163548_26.png

expound 发表于 2025-3-26 06:05:15

Steroid Sparing Therapies in Asthma,The recognition that asthma is a consequence of airway inflammation has focused treatment goals towards anti-inflammatory agents. Inhaled and systemic corticosteroids are of proven benefit and inhaled steroids are so effective that systemic corticosteroids are usually reserved for acute exacerbations of the condition.

mechanism 发表于 2025-3-26 11:19:34

http://reply.papertrans.cn/17/1636/163548/163548_28.png

Venules 发表于 2025-3-26 13:21:04

https://doi.org/10.1007/978-3-663-12119-0accepted epidemiological definition of the condition. Existing definitions of asthma in adults are more descriptive than definitive, focussing on the clinical characteristics of reversible airways obstruction, chronic airway inflammation, and increased bronchial responsiveness to a variety of stimul

gentle 发表于 2025-3-26 18:44:53

http://reply.papertrans.cn/17/1636/163548/163548_30.png
页: 1 2 [3] 4 5
查看完整版本: Titlebook: Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends; Mark A. Giembycz,Brian J. O’Connor Book 2000 Springer Basel AG 2000 Atm